Stock Analysts

UberEats Gains Momentum, Should GrubHub (GRUB) Worry?

Popular ride hailing service Uber is rapidly making its way into the food delivery business posing stiff competition to its peers like GrubHub Inc. GRUB and its Seamless division. The UberEATS service, rolled out earlier this year through the common Uber app, is now being made available through a separate dedicated app […]

Stock Analysts

Novo Nordisk Files Faster-Acting Insulin Aspart NDA in U.S.

Novo Nordisk NVO announced that it submitted a New Drug Application (NDA) for faster-acting insulin aspart to the FDA. This mealtime insulin is being developed for improved control of postprandial glucose excursions and for the treatment of people with type I and type II diabetes. Novo Nordisk filed for the candidate based on positive results from the clinical onset trial, wherein approximately 2100 patients with type I and II diabetes were treated. […]

Mergers & Acquisitions

J.P. Morgan Asset Management – SunEdison Strategic Partnership Acquires 333 Megawatts of Wind-Power Plants from SunEdison

J.P. Morgan Asset Management – SunEdison Strategic Partnership Acquires 333 Megawatts of Wind-Power Plants from SunEdison – SunEdison – J.P. Morgan Asset Management partnership, called Terra Nova Renewable Partners, acquires the Bingham and Oakfield wind farm assets for $209 million in equity – Enterprise value of the deal is $787 million – SunEdison has the right to repurchase the assets held by the partnership for up to five years PR Newswire MARYLAND HEIGHTS, Mo., Dec. […]

Stock Analysts

Petrobras Intends to Divest 10% Interest in Libra Oil Field

Petroleo Brasileiro S.A. or Petrobras PBR is planning to divest up to one-fourth of its 40% interest in the Libra oil field − located off the coast of Rio de Janeiro, Brazil − for $1.5 billion, going by Reuters. This reflects the company’s intention to lower its huge load of debt, the highest in the entire oil industry. […]

Stock Analysts

OncoGenex to Continue with Borealis-2 Study on Apatorsen

OncoGenex Pharmaceuticals, Inc. OGXI announced that the independent Data Safety Monitoring Board has recommended continuation of phase II Borealis-2 study on apatorsen, after it completed the pre-specified futility analysis. The investigator-sponsored, randomized study will evaluate apatorsen in combination with Taxotere (docetaxel) treatment compared to Taxotere as monotherapy, in patients with metastatic bladder cancer who experienced disease progression following first-line platinum-based chemotherapy […]

Stock Analysts

Unisys Appoints 3 New Heads to Boost Business Competency

Premium information technology service company Unisys Corporation UIS recently announced three important leadership appointments within its Enterprise Solutions unit, to help expand its regional and vertical industry capabilities. The appointed professionals would serve the company’s clients staying outside the U.S. Federal market […]

Stock Analysts

Jones Lang LaSalle’s (JLL) Acquisition Drive Continues

Jones Lang LaSalle Incorporated JLL has lately been on an acquisition spree. Recently, the company acquired the Rosebank, Johannesburg-based Trussard Property Consultants to boost its South African business. Moreover, this Chicago-based real estate operations firm is set to ink a deal for acquiring Big Red Rooster to expand its Project and Development Services (“PDS”) and Retail businesses. […]

Stock Analysts

Pfizer/Merck KGaA Begin Two Phase III Studies on Avelumab

Pfizer Inc. PFE and Merck KGaA MKGAF announced the initiation of two multi-center, randomized, open-label phase III studies – JAVELIN Gastric 100 and JAVELIN Gastric 300 – on their experimental anti-PD-L1 IgG1 monoclonal antibody avelumab, for the treatment of patients suffering from advanced or metastatic gastric/gastro-esophageal junction (GEJ) cancers. The JAVELIN Gastric 100 study will evaluate the superiority of avelumab immunotherapy as a first-line maintenance treatment of patients with unresectable, locally advanced or metastatic gastric/GEJ cancers whose disease has not progressed with first-line platinum-based chemotherapy. […]

Mergers & Acquisitions

Fidelity Investments Canada ULC announces fund mergers and closures

Fidelity Investments Canada ULC announces fund mergers and closures Canada NewsWire TORONTO, Dec. 10, 2015 TORONTO , Dec. 10, 2015 /CNW/ – Fidelity Investments Canada ULC (“Fidelity Canada”) is announcing the merger of Fidelity American Opportunities Fund and Fidelity American Opportunities Class into Fidelity American Equity Fund and Fidelity American Equity Class, respectively. […]